Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Over $500 million in insider stock sales have hit three high-profile companies this month—an unsettling signal that even top executives and major stakeholders may be questioning the sustainability of recent gains.
| Health Care Equipment & Supplies Industry | Healthcare Sector | Kevin A. Lobo CEO | XMEX Exchange | US8636671013 ISIN |
| US Country | 53,000 Employees | 31 Dec 2025 Last Dividend | 17 May 2004 Last Split | - IPO Date |
Stryker Corporation is a leading medical technology company with a primary focus on providing innovative solutions in the medical field. The company operates through two main segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. These segments cater to a wide array of medical needs, from total joint replacements and trauma surgeries to advanced neurosurgical and neurovascular solutions. Founded in 1941 and based in Portage, Michigan, Stryker has grown into a global entity, distributing its products in approximately 75 countries. The company's commitment to enhancing patient and caregiver outcomes is evident through its extensive product portfolio, advanced medical devices, and a strategic approach to market distribution and customer engagement.
Stryker Corporation offers a diverse range of products and services designed to cater to various facets of medical care, spanning various specialties and requirements. These include:
These products are made available to doctors, hospitals, and other healthcare facilities through a blend of company-owned subsidiaries and branches, supplemented by a network of third-party dealers and distributors worldwide.